10 / 22
Page 43
S e p t e m b e r 0 6 - 0 7 , 2 0 1 8 | B a n g k o k , T h a i l a n d
allied
academies
Joint Event on
Global Women Health 2018 & Orthopedics Congress 2018
Archives of General Internal Medicine
|
ISSN: 2591-7951
|
Volume 2
BREAST CANCER, GYNECOLOGY AND WOMEN HEALTH
ORTHOPEDICS AND RHEUMATOLOGY
&
World Congress on
Annual Conference on
Arch Gen Intern Med 2018, Volume 2 | DOI: 10.4066/2591-7951-C3-009
PHARMACOKINETIC AND TOLERABILITY STUDY OF JNP0201, A NOVEL
17Β-ESTRADIOL AND PROGESTERONE INTRAVAGINAL RING, IN SHEEP
Herman Weiss
1
, Bridget A Martell
2
,
Elaine R Richardson
3
and
Laurie A Iciek
4
1
Juniper Pharmaceuticals Inc, USA
2
Yale University School of Medicine, USA
3
Richardson Consulting Services LLC, USA
4
Biologics Consulting Group Inc, USA
Objective:
To evaluate the pharmacokinetics and local tolerability of JNP0201, a novel intravaginal ring delivering 17β-estradiol and
progesterone, in drug-naïve ovariectomized female Dorset crossbred sheep.
Methods:
Animals were randomized to treatment groups one or two (comparator ring, with 50 or 100 μg/day 17β-estradiol,
respectively, N=5), groups three or four (JNP0201, 160 μg/day 17β-estradiol with five and 10 mg/day progesterone, respectively,
N=5), or group five (160 µg 17β-estradiol and 10 mg progesterone intravenously, N=3). Intravaginal rings were placed on day one
and remained in place through day 29. Animals underwent daily examinations to confirm ring placement, and external vaginal
irritation was scored from 0 (none) to four (severe). Blood samples were taken at scheduled times for pharmacokinetic analysis.
Postmortem examinations performed on groups 1-4 included internal vaginal irritation, macroscopic and microscopic evaluations,
including irritation scoring and histopathology.
Results:
Intravaginal rings were retained over 28 days in all but one animal (group four). Clinical observations showed no significant
abnormal findings. Pharmacokinetic analysis in JNP0201 animals showed sustained release of 17β-estradiol and progesterone
(respective area under the curve 0-672 hours: group 3: 17,400 pg*hr/mL and 240,000 pg*hr/mL; group 4: 21,000 pg*hr/mL and
485,000 pg*hr/Ml). For both external and internal vaginal irritation, mean scores were typically 0-1 and did not exceed two for any
group. Irritation scores and microscopic assessments were consistent with foreign object placement; microscopic tests showed
minimal to mild leukocytic infiltration and ulceration.
Conclusions:
JNP0201 intravaginal rings were well tolerated. Pharmacokinetic results will be used to guide future human clinical
studies.